Industry revenue of “manufacture of basic pharmaceutical products“ in Switzerland 2012-2024

With some of the world’s leading pharmaceutical companies such as Novartis and Roche headquartered in the nation, it isn’t surprising to see why the Swiss pharmaceutical products manufacturing industry has been thriving. The industry, which consists of manufacturing basic pharmaceutical products and preparations, was valued at 61 billion U.S. dollars in 2012 and is projected to grow 45 percent by 2024. Moreover, the industry is one of the biggest in Europe, employing over 46,000 people and contributes to over 30 percent of the country’s exports.

Stores tap into medicine reserves amid rising Covid-19 cases

Medical stores in Switzerland have begun tapping into their reserves that were set aside for crisis, as the demand for medicines is soaring due to the rising number of cases in the nation. Demand is particularly high in the canton of Ticino, which is amongst the worst hit, with approximately 470 cases per 100,000 inhabitants, nearly thrice the national rate.

Roche develops new serology test

Roche has announced the development of a new serology test to help identify people who have been infected by Covid-19 virus. It aims to have the test available in countries accepting the CE mark by early May. Moreover, the firm is also working collaboratively with the FDA on a clinical trial to see if certain drugs can work as a treatment for patients hospitalized with severe COVID-19 pneumonia.

Industry revenue of “manufacture of basic pharmaceutical products“ in Switzerland from 2012 to 2024

Exclusive Corporate Account feature

To view this statistic you need a Corporate Account, which includes the following benefits

  • Access to all content
  • Download as XLS, PPT, PNG and PDF
  • Detailed source and background information
Corporate Account
$700 per month*
(billed annually)
* All products require an annual contract; Prices do not include sales tax.
Show detailed source information?
Register for free
Already a member?
Log in

Supplementary notes

* Estimate - This also applies for past years as data provided by statistical institutions often is not available for more recent years.

Currency conversion factor: (EUR -> USD) = 1.123

The industry classification is based on the NACE Rev.2 - system in Switzerland. The industry “manufacture of basic pharmaceutical products and pharmaceutical preparations“ has the code “C21“.

Details on the methodology can be found here.

Please visit here for more information on Statista market forecasts.

Use Statista now: unlimited access to all content

Statistics on "Economic Outlook Switzerland"

Further Content: You might find this interesting as well


Use Statista now: unlimited access to all content
Learn more about how Statista can support your business.